先天性甲状腺功能减退症病例中的DUOX1和DUOX2双基因突变
本文报告一个家系中先证者及其兄弟携带DUOX2纯合无义突变(p.R434*)导致异常严重的先天性甲状腺功能减退症,后续研究检出与CH共分离的DUOX1纯合突变(c.1823-1G>C),导致异常剪接和蛋白截断(p.Val607Aspfs*43)。作者提出DUOX1不能代偿DUOX2缺陷可能解释该家系的严重CH表型,为CH的双基因基础提供证据,并支持寡基因及环境调节因素可导致遗传确诊CH的表型变异。
要点
- 先证者及其兄弟携带DUOX2纯合无义突变(p.R434*),表现为异常严重的先天性甲状腺功能减退症。
- 后续检出与CH共分离的DUOX1纯合突变(c.1823-1G>C),导致异常剪接和蛋白截断(p.Val607Aspfs*43)。
- 作者提出DUOX1不能代偿DUOX2缺陷可能解释该家系的严重CH表型,为CH的双基因基础提供证据。
核心结论
- 本文报告DUOX1和DUOX2双基因突变与先天性甲状腺功能减退症相关,作者提出该家系中DUOX1不能代偿DUOX2缺陷可能解释严重CH表型。
- 作者认为其研究为CH的双基因基础提供证据,并支持寡基因及环境调节因素可导致遗传确诊CH的表型变异。
研究设计与样本
- 本文为病例报告,描述一个家系中先证者及其兄弟(P1、P2)的临床与遗传学发现。
主要发现
- 先证者及其兄弟(P1、P2)携带DUOX2纯合无义突变(p.R434*),表现为异常严重的先天性甲状腺功能减退症。
- P1、P2促甲状腺激素>100 µU/mL(参考范围0.5至6.3)。
- P1游离T4(FT4)<0.09 ng/dL(参考范围0.9至2.3)。
- 后续研究检出DUOX1纯合突变(c.1823-1G>C),导致异常剪接和蛋白截断(p.Val607Aspfs*43),并与该家系CH共分离。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The DUOX2 enzyme generates hydrogen peroxide (H2O2), a crucial electron acceptor for the thyroid peroxidase-catalyzed iodination and coupling reactions mediating thyroid hormone biosynthesis. DUOX2 mutations result in dyshormonogenetic congenital hypothyroidism (CH) that may be phenotypically heterogeneous, leading to the hypothesis that CH severity may be influenced by environmental factors (e.g., dietary iodine) and oligogenic modifiers (e.g., variants in the homologous reduced form of NAD phosphate-oxidase DUOX1). However, loss-of-function mutations in DUOX1 have not hitherto been described, and its role in thyroid biology remains undefined. CASE DESCRIPTION: We previously described a Proband and her brother (P1, P2) with unusually severe CH associated with a DUOX2 homozygous nonsense mutation (p.R434*); P1, P2: thyrotropin >100 µU/mL [reference range (RR) 0.5 to 6.3]; and P1: free T4 (FT4) <0.09 ng/dL (RR 0.9 to 2.3). Subsequent studies have revealed a homozygous DUOX1 mutation (c.1823-1G>C) resulting in aberrant splicing and a protein truncation (p.Val607Aspfs*43), which segregates with CH in this kindred. CONCLUSION: This is a report of digenic mutations in DUOX1 and DUOX2 in association with CH, and we hypothesize that the inability of DUOX1 to compensate for DUOX2 deficiency in this kindred may underlie the severe CH phenotype. Our studies provide evidence for a digenic basis for CH and support the notion that oligogenicity as well as environmental modulators may underlie phenotypic variability in genetically ascertained CH.
引用
- Aycan Z, Cangul H, Muzza M, et al. Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism. J Clin Endocrinol Metab. 2017. PMID: 28633507. doi:10.1210/jc.2017-00529
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。